Skip to content

Effect of Transfer of Energy Capacitive and Resistive on Chronic Discogenic Sciatica

RecruitingNot applicableNCT07841405
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this clinical trial is to evaluate the effect of Transfer of Energy Capacitive and Resistive (TECAR) on pain, functional disability and electrophysiological parameters in adults with chronic discogenic sciatica . The main questions it aims to answer are: • Is there significant effect of TECAR therapy on pain, functional disability and Electrophysiological parameters (H-reflex latency and amplitude) ? Researchers will compare effect of adding TECAR therapy to conventional physical therapy program (TENS, hot pack, stretching exercises and core stability exercises) Vs conventional physical therapy program alone to see if there is a beneficial effect of adding TECAR therapy to physical therapy program Participants in study group will receive TECAR therapy in addition to conventional PT program while participants in control group will receive conventional PT program

Study details

Official title
Effect of Capacitive and Resistive Energy Transfer on Pain, Functional Outcome and Electrophysiological Parameters in Patients With Chronic Discogenic Sciatica
Interventions
  • Device: Transfer of Energy Capacitive and Resistive (TECAR) therapy
  • Other: conventional physical therapy program
Sponsor
Cairo University
Start date
2026-09-21
Primary completion
2027-01-21
Sex
Male
Age range
from 35 Years to 50 Years
Results posted
No results posted in this snapshot
Countries
Egypt
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 30-50 years * Unilateral chronic discogenic sciatica at L5-S1, MRI confirmed * Symptom duration more than 3 months * Pain score ≥ 4 on the Visual Analogue Scale (VAS) * Ability to participate in outpatient physiotherapy Exclusion Criteria: * Previous lumbar spine surgery * Pacemaker or metallic implants * Peripheral neuropathy or systemic neurological disorders * Severe sensory loss * Skin lesions at the treatment site * Recent corticosteroid injection (\< 3 weeks)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07841405